Demystifying the management of hypertriglyceridemia
EAS Academy. Tybjaerg-Hansen A. 04/25/17; 175521 Topic: Therapy
Prof. Dr. Anne Tybjaerg-Hansen
Prof. Dr. Anne Tybjaerg-Hansen

Free Content is available to all users. Create a sign in with just your name and email.


Access EAS content "anytime, anywhere" with the EAS Academy App for iOS and Android


For any questions contact us at office@eas-society.org


Abstract
Discussion Forum (0)
Rate & Comment (0)
A presentation by Professor Anne Tybjaerg-Hansen from Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. In this presentation we get basics on triglycerides and CVD risk and are also taken through the underlying genetic studies, primarily based on the data from Copenhagen. Furthermore Professor Tybjaerg-Hansen tells us about the new treatment targets that are being developed based on Mendelian randomization studies.
A presentation by Professor Anne Tybjaerg-Hansen from Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. In this presentation we get basics on triglycerides and CVD risk and are also taken through the underlying genetic studies, primarily based on the data from Copenhagen. Furthermore Professor Tybjaerg-Hansen tells us about the new treatment targets that are being developed based on Mendelian randomization studies.
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies